Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
📈 Q1 Earnings Alert! Critical earnings dates you can't miss
See Calendar
Blackrock Advantage International Fund Investor A Shares (BROAX)
Add to/Remove from a Portfolio
Add to Watchlist
20.52
+0.04
+0.20%
25/04 - Closed. Currency in USD
- Morningstar Rating:
- Total Assets: 338.71M
BlackRock Global Opportunities Inv A
20.52
+0.04
+0.20%
- General
- Chart
- News & Analysis
- Technical
- Forum
- Overview
- Profile
- Historical Data
- Holdings
BROAX Overview
On this page you'll find an in-depth profile of Blackrock Advantage International Fund Investor A Shares. Learn about the key management, total assets, investment strategy and contact information of BROAX among other information.
Contact Information
Address
12 Throgmorton Avenue
London,RI EC2N 2DL
United Kingdom
London,RI EC2N 2DL
United Kingdom
Phone
020 7743 3000
Top Executives
| Name | Title | Since | Until |
|---|---|---|---|
| Kevin Franklin | Managing Director | 2017 | Now |
| Biography | Kevin Franklin is a member of BlackRock's Systematic Active Equity Investment Group. He is responsible for BlackRock's Global Equity Strategies. Mr. Franklin rejoined the firm in 2010, building on five prior years of service with Barclays Global Investors (BGI), which merged with BlackRock in 2009. He joined BlackRock after a year as head of Automated Trading at Marble Bar Asset Management in London, where he was responsible for MBAM's European systematic equity long-short product. At BGI, his previous roles include head of Portfolio Management for The 32 Capital Fund equity long-short strategy, as well as head of Market Neutral, Europe Active Equities. Prior to joining BGI, Mr. Franklin was a portfolio manager and trader at Horizon Asset Limited. Mr. Franklin earned a BS degree in applied physics and history from the California Institute of Technology in 2000. | ||
| Richard Mathieson | Managing Director | 2017 | Now |
| Biography | Richard Mathieson, CA, Managing Director of BlackRock, Inc. since 2011; Director of BlackRock, Inc. from 2009 to 2011; Principal at Barclays Global Investors from 2008 to 2009; Equity Analyst for Exista UK from 2007 to 2008; Principal at Barclays Global Investors from 2005 to 2007; Associate of Barclays Global Investors from 2001 to 2005. Mr. Mathieson is a member of the Systematic Active Equity division within BlackRock's Active Equities Group. He is a Portfolio Manager responsible for global equity strategies. Prior to this he led the Investment Strategy team in EMEA for Scientific Active Equity. Mr. Mathieson's service with the firm dates back to 2002, including his years with Barclays Global Investors (BGI), which merged with BlackRock in 2009. Prior to rejoining BGI in 2008, Mr. Mathieson was an equity analyst for a specialist investment company focused on European financial stocks. Previously he was with BGI as a senior portfolio manager, where he was responsible for managing both long only and market neutral strategies. Prior to joining the BlackRock, Inc. in 1999, Robert was a mortgage banking specialist at Ohio Savings Bank. Mr. Mathieson qualified as a Chartered Accountant with PricewaterhouseCoopers in 2000, and holds a Bachelor of Accountancy from the University of Glasgow | ||
| Raffaele Savi | Managing Director | 2017 | Now |
| Biography | Raffaele Savi, Senior Managing Director, is Global Head of BlackRock Systematic (BSYS) and Co-CIO and Co-Head of Systematic Active Equity (SAE). He is a member of BlackRock’s Global Executive Committee and its Investment Sub Committee. As head of BSYS, Mr. Savi leads the firm’s quantitative investing teams, including fixed income, equity and factor strategies. In 2006, Mr. Savi joined Barclay's Global Investors (BGI), which merged with BlackRock in 2009. At BGI, Mr. Savi was global head of portfolio management for active equities and also served as its head of investments for European active | ||
| Simon McGeough | Director | 2015 | 2017 |
| Biography | Simon McGeough jointly and primarily responsible as Director of BlackRock, Inc. since 2011; Member of BlackRock’s European equity team from 2007 to 2010. | ||
| Ian Jamieson | Director, Portfolio Manager | 2011 | 2017 |
| Biography | Mr. Jamieson is lead portfolio manager for the consumer durables, retail, autos, and telecom industries, product manager for Global and International equity portfolios, and a member of the team's Investment Strategy Group. Before joining BlackRock in 1999, Mr. Jamieson was a client relationship manager with Morgan Stanley Institutional Investment Management from 1996 to 1999. He began his career as an investment broker at RAF Financial in 1995. Mr. Jamieson earned a BS degree in finance from Pennsylvania State University in 1995. | ||
| Thomas P. Callan | Managing Director | 2006 | 2017 |
| Biography | Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981. | ||
| Nigel Hart | Managing Director | 2012 | 2014 |
| Biography | Nigel Hart, CFA. Managing Director of BlackRock, Inc. since 2012; Managing Partner and Portfolio Manager of ReachCapital Management LP from 2000 to 2010. Hart is vice president and portfolio manager with Putnam Investments, his employer since 1997. Prior to joining the firm, he was a vice president and portfolio manager with IAI International from 1991 to 1997. Previously, he was an investment analyst with Commercial Union Asset Management from 1989 to 1991. He has eight years of investment experience. Hart holds the Chartered Financial Analyst designation. | ||
| Michael D. Carey | Managing Director/Portfolio Manager | 2006 | 2012 |
| Biography | "Michael D. Carey, CFA, Managing Director and Portfolio Manager, is a member of BlackRock's Global Opportunities equity team. He is a portfolio manager for International Small Cap equity portfolios and a strategist for all of the team's products. Prior to joining BlackRock in 1998, Mr. Carey was an investment strategist with the PNC Asset Management Group. He began his career as a fixed income analyst with PNC in 1992. Mr. Carey earned a BS degree in commerce and engineering with a concentration in finance from Drexel University in 1991, and an MS degree in statistics from Temple University in 1996." | ||
| Andrew Gordon | Managing Director | 2006 | 2008 |
| Biography | Andrew Gordon, Managing Director and portfolio manager, is head of BlackRock's global bond team within the Fixed Income Portfolio Management Group.Before joining BlackRock in 1996, Andrew developed strategies for a small relative value global fixed income hedge fund, having previously worked for CS First Boston and in the International Research and Open Market Operations departments of the Federal Reserve Bank of New York. | ||
| Erin Xie | Managing Director | 2006 | 2008 |
| Biography | Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock’s Active Equity Group. She is the lead portfolio manager for the Health Sciences equity portfolios. Ms. Xie's service with the firm dates back to 2001, including her years with State Street Research & Management (SSRM), which merged with BlackRock in 2005. At SSRM, she was a Senior Vice President and portfolio manager responsible for managing the State Street Health Sciences Fund. Prior to joining State Street Research in 2001, Ms. Xie was a research associate with Sanford Bernstein covering the pharmaceutical industry from 1999. From 1994 until 1997, she was a post doctoral research scientist at Columbia University. Ms. Xie earned a BS degree in chemistry from Beijing University in 1988, a PhD degree in Biochemistry from the University of California, Los Angeles, in 1993 and a MBA degree from the Massachusetts Institute of Technology Sloan School of Management in 1999. | ||
Write your thoughts about Blackrock Advantage International Fund Investor A Shares
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review